Howard Hutchinson - Articles and news items

Bristol Myers Squibb logo

ONGLYZA® (saxagliptin) approved for use in Europe as combination therapy with insulin in adults with type 2 diabetes

Industry news, News / 28 November 2011 / Bristol-Myers Squibb Company

The European Commission has approved ONGLYZA® (saxagliptin)…


SATURN demonstrated effect of intensive statin treatment on reducing atherosclerosis

Industry news, News / 15 November 2011 / AstraZeneca

Data presented at this year’s AHA reinforces the established efficacy profile of CRESTOR…


FDA approves orphan drug vandetanib

Industry news, News / 7 April 2011 / AstraZeneca

AstraZeneca today announced that the FDA approved the orphan drug vandetanib for the treatment of medullary thyroid cancer…

US FDA Advisory Committee Makes Recommendation on New Drug Application for Vandetanib in Advanced Medullary Thyroid Cancer

Industry news, News / 2 December 2010 / AstraZeneca

AstraZeneca announced the outcome of the US FDA Advisory Committee meeting…

KOMBIGLYZE™ XR tablets approved in the US for the treatment of type 2 diabetes mellitus in adults

Industry news, News / 5 November 2010 / AstraZeneca

AstraZeneca & Bristol-Myers Squibb Company announced that the US FDA approved KOMBIGLYZE™ XR…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...